Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Oct 1;184(4):1519-24.
doi: 10.1084/jem.184.4.1519.

Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients

Affiliations

Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients

I B McInnes et al. J Exp Med. .

Abstract

We have demonstrated spontaneous nitric oxide (NO) production by primary synovial cultures from rheumatoid (RA) and osteoarthritis patients. Increased NO production followed addition of staphylococcal enterotoxin B. Immunochemical double staining with specific anti-human inducible NO synthase (iNOS) and nonspecific esterase (NSE), or anti-CD68 (markers for tissue macrophages) showed that although many lining layer cells in RA synovium expressed iNOS, most (approximately 90%) were NSE- and CD68-, with only a minor population (approximately 10%) which were iNOS+, CD68+/NSE+. These data demonstrate the capacity for high output of NO by human synovial tissue and show that, although human macrophages can express high levels of iNOS, the majority of cells expressing iNOS are fibroblasts. We also report that synoviocytes, and macrophage cell lines, cultured with the NO donor, S-nitroso-acetyl penicillamine, produced high concentrations of tumor necrosis factor (TNF)-alpha. These results suggest that NO may mediate pathology in RA through the induction of TNF-alpha production.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Immunol. 1975 Apr;5(4):270-4 - PubMed
    1. Annu Rev Immunol. 1996;14:397-440 - PubMed
    1. Lancet. 1989 Jul 29;2(8657):244-7 - PubMed
    1. Science. 1990 May 11;248(4956):705-11 - PubMed
    1. J Immunol. 1991 Apr 1;146(7):2310-5 - PubMed

Publication types